← All organizations
Antengene Corporation
For profitWebsite ↗
Also known as: Antengene Biologics Limited | Antengene Corporation | Antengene Discovery Limited | Antengene (Hangzhou) Biologics Co., Ltd. | Antengene Therapeutics Limited | Guoxue lane, Chengdu, Sichuan | Medical Monitor | Shanghai Antengene Corporation Limited
Highest phase reached
Phase 3
First clinical trial
Aug 7, 2018Last known activity
Dec 31, 2024
Timeline
2010s
- Jun 1, 2016
Antengene Corporation— Founded
Drugs by trial phase (48 distinct, 31 trials)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (24 own, 0 via acquisition)
Phase 1 (17 own, 0 via acquisition)
Indications
Recent trials (36)
- NCT06665165OfficialPhase 1Dec 31, 2024
- NCT06028373Lead sponsorPhase 1Oct 13, 2023
- NCT05698147CollaboratorPhase 1/Phase 2Aug 3, 2023
- NCT05718895Lead sponsorPhase 1Mar 27, 2023
- NCT05726110CollaboratorPhase 3Jan 29, 2023
- NCT05205109Lead sponsorPhase 1Dec 31, 2022
- NCT05448820Study directorPhase 1/Phase 2Nov 14, 2022
- NCT05577364CollaboratorPhase 1/Phase 2Nov 1, 2022
- NCT05422066CollaboratorPhase 2Jul 26, 2022
- NCT05422027CollaboratorPhase 1/Phase 2Jul 25, 2022
- NCT05338346Lead sponsorPhase 1Jun 1, 2022
- NCT05265975Lead sponsorPhase 1/Phase 2Apr 7, 2022
- NCT05265975Study directorPhase 1/Phase 2Apr 7, 2022
- NCT05279859Study directorPhase 1/Phase 2Mar 15, 2022
- NCT05354362Study directorPhase 1Mar 2, 2022
Details
- Founded
- Shanghai, CN Jun 1, 2016
- Last known activity
- Dec 31, 2024